Corneal epithelial cells were lysed by shaking at 4°C for 30 minutes in RIPA buffer (50 mM Tris-HCl, 1% NP-40, 0.25% Na-deoxycholate, 150 mM NaCl, 1 mM Na3VO4, and NaF) containing protease inhibitors (1 μg/mL each of aprotinin, leupeptin, pepstatin, EDTA, phenyl methyl sulfonyl fluoride [PMSF]). Remnants were detached using a cell scraper, and lysates were transferred to Eppendorf tubes and centrifuged at 12000g for 15 minutes at 4°C. The supernatant was transferred to a new microfuge tube, mixed with sample buffer (12 mM Tris-HCl, 96 mM glycine, 10% SDS, 1% 2-mercaptoethanol, and 0.1% bromophenol blue, pH 6.8), and boiled for 5 minutes. Total protein was determined by the BCA protein assay (Pierce, Rockford, IL), and equal protein concentrations were loaded onto an 8% polyacrylamide gel using a 5% stacking gel. Samples, containing equal protein loadings, were subjected to SDS-PAGE. Resolved proteins were transferred to a nitrocellulose membrane and were probed with anti-human Notch1 (1:200), Notch2 (1:200), Jagged1 (1:200), Delta1 (1:200; all from Santa Cruz Biotechnology, Autogen-BioClear, UK), rabbit anti–Ki67 (1:100; DakoCytomation, Glostrup, Denmark), and monoclonal anti–CK3 (1:200; MP Biomedicals, Inc, Aurora, OH) antibodies for 2 hours at room temperature, followed by incubation for 1 hour in appropriate secondary antibodies conjugated with horseradish peroxidase (HRP; 1:1000; Santa Cruz Biotechnology, Santa Cruz, CA). The enhanced chemiluminescence (ECL) system (Santa Cruz) was used to develop immunopositive bands.